Profile data is unavailable for this security.
About the company
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
- Revenue in SEK (TTM)36.58m
- Net income in SEK-90.39m
- Incorporated2008
- Employees34.00
- LocationSciBase Holding AB (publ)Landsvagen 39SUNDBYBERG 172 63SwedenSWE
- Phone+46 841062000
- Fax+46 86152224
- Websitehttps://scibase.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scandinavian Medical Solutions A/S | 350.30m | 37.11k | 141.68m | 28.00 | 5,409.09 | 1.20 | 11.34 | 0.4044 | 0.0007 | 0.0007 | 8.88 | 2.99 | 1.29 | 1.94 | 11.19 | -- | 0.0137 | 6.59 | 0.0246 | 11.68 | 23.12 | 24.88 | 0.0106 | 4.68 | 0.3524 | 1.14 | 0.4345 | -- | 8.28 | 42.38 | -99.67 | -64.34 | -- | -- |
| Bioretec Oy | -1.07tn | -1.07tn | 149.70m | 57.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -57.56 | -- | -77.31 | -- | 70.90 | -- | -128.20 | -- | -- | -- | -- | 16.32 | 21.07 | -21.78 | -- | -- | -- |
| iZafe Group AB | 5.90m | -17.73m | 161.89m | 10.00 | -- | 9.83 | -- | 27.43 | -0.0614 | -0.0614 | 0.0194 | 0.0452 | 0.1757 | 3.44 | 8.15 | 843,000.00 | -52.78 | -57.76 | -73.42 | -72.44 | -106.29 | -287.24 | -300.41 | -630.90 | 0.9122 | -17.45 | 0.0198 | -- | 336.55 | -11.10 | 36.26 | -- | -24.50 | -- |
| Bactiquant A/S | 11.79m | -18.67m | 165.74m | -- | -- | 11.37 | -- | 14.06 | -0.4696 | -0.4696 | 0.2966 | 0.2723 | 0.4656 | 2.69 | 15.14 | -- | -73.73 | -55.41 | -85.85 | -64.53 | -31.80 | -10.94 | -158.37 | -121.81 | 3.26 | -9.70 | 0.1926 | -- | -41.68 | -14.27 | -4.72 | -- | -- | -- |
| Ortivus AB | 75.91m | -24.74m | 168.25m | 34.00 | -- | -- | -- | 2.22 | -0.5583 | -0.5583 | 1.71 | -0.5062 | 1.18 | 6.77 | 16.22 | 2,372,281.00 | -38.46 | -4.62 | -147.30 | -8.65 | 34.79 | 41.27 | -32.59 | -3.55 | 0.4719 | -4.01 | 1.72 | -- | -4.36 | 9.60 | -36.49 | -- | 65.37 | -- |
| BrainCool AB (publ) | 43.62m | -36.85m | 177.70m | 20.00 | -- | 1.00 | -- | 4.07 | -0.1408 | -0.1408 | 0.1666 | 0.4479 | 0.2841 | 1.15 | 2.92 | 2,180,769.00 | -24.00 | -38.93 | -26.22 | -53.10 | 29.86 | 48.00 | -84.48 | -233.83 | 2.29 | -33.11 | 0.00 | -- | 72.05 | 56.50 | 28.13 | -- | 4.34 | -- |
| Micropos Medical AB (publ) | 8.46m | -20.21m | 178.15m | 9.00 | -- | 8.99 | -- | 21.05 | -0.1296 | -0.1296 | 0.0538 | 0.1191 | 0.3797 | -0.0031 | 5.09 | 1,057,905.00 | -90.68 | -74.98 | -115.26 | -98.65 | 100.15 | 87.53 | -238.83 | -670.95 | 4.49 | -70.70 | 0.00 | -- | 133.47 | 36.60 | 7.09 | -- | -- | -- |
| Boule Diagnostics AB | 512.66m | -80.68m | 194.17m | 186.00 | -- | 1.15 | -- | 0.3787 | -2.09 | -2.09 | 13.33 | 4.34 | 1.03 | 4.61 | 4.04 | 2,268,420.00 | -16.14 | -9.09 | -28.43 | -13.28 | 42.88 | 43.62 | -15.74 | -11.16 | 0.7753 | 23.70 | 0.5491 | -- | -2.25 | 2.28 | -1,287.41 | -- | 7.84 | -- |
| Subgen AI AB | 0.00 | -64.18m | 209.86m | 15.00 | -- | -- | -- | -- | -544.10 | -544.10 | 0.00 | -25.11 | 0.00 | -- | -- | 0.00 | -188.83 | -- | -403.12 | -- | -- | -- | -- | -- | -- | -4.46 | -- | -- | -100.00 | -- | 16.86 | -- | -- | -- |
| SciBase Holding AB (publ) | 36.58m | -90.39m | 219.52m | 34.00 | -- | 3.93 | -- | 6.00 | -0.2487 | -0.2487 | 0.0978 | 0.0674 | 0.6648 | 1.29 | 3.23 | 1,143,250.00 | -164.26 | -75.65 | -244.76 | -101.01 | 66.04 | 65.08 | -247.08 | -256.98 | 2.07 | -11.75 | 0.00 | -- | 27.79 | 26.21 | -9.97 | -- | -20.49 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -35.57m | 225.48m | 21.00 | -- | 1.24 | -- | -- | -4.03 | -4.03 | 0.00 | 15.08 | 0.00 | -- | -- | 0.00 | -19.97 | -- | -24.07 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 80.11 | -- | -1.65 | -- |
| Integrum AB | 97.00m | -29.85m | 228.79m | 37.00 | -- | 1.21 | -- | 2.36 | -1.37 | -1.37 | 4.50 | 7.26 | 0.5253 | 0.828 | 3.40 | 2,487,052.00 | -16.17 | -3.58 | -17.87 | -4.08 | 75.61 | 83.88 | -30.78 | -6.47 | 1.88 | -- | 0.025 | -- | -12.50 | 27.78 | -864.22 | -- | 103.14 | -- |
| Clinical Laserthermia Systems AB | 21.27m | -38.38m | 238.40m | 16.00 | -- | 3.30 | -- | 11.21 | -5.02 | -5.02 | 1.08 | 2.32 | 0.3208 | 4.58 | 4.84 | 1,329,313.00 | -57.98 | -116.28 | -63.60 | -248.44 | -63.75 | -556.78 | -180.75 | -872.82 | 2.55 | -5.79 | 0.0039 | -- | 127.04 | 67.47 | 40.32 | -- | -- | -- |
| Karolinska Development AB | 1.74m | -135.74m | 243.69m | 8.00 | -- | 0.0789 | -- | 140.21 | -0.4096 | -0.4096 | 0.0052 | 3.28 | 0.0015 | -- | 0.6263 | 217,250.00 | -11.69 | -2.23 | -11.78 | -2.37 | -- | -- | -7,810.36 | -1,161.99 | -- | -1.49 | 0.0017 | -- | -8.74 | -11.49 | -250.41 | -- | -- | -- |
| ContextVision AB | 112.48m | 3.57m | 268.61m | 44.00 | 75.97 | 2.97 | 23.59 | 2.39 | 0.0491 | 0.0491 | 1.58 | 1.25 | 0.9575 | 1.74 | 4.15 | 3,020,009.00 | 3.04 | 30.51 | 3.71 | 45.07 | 97.62 | 98.49 | 3.17 | 28.49 | 4.70 | -- | 0.0847 | -- | -1.15 | 6.51 | -24.60 | 27.25 | -30.69 | -- |
| INIFY Laboratories AB | 20.10m | -61.30m | 288.67m | 34.00 | -- | 2.20 | -- | 14.36 | -1.15 | -1.15 | 0.3729 | 1.73 | 0.1928 | 2.96 | 3.12 | 863,607.90 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to SciBase Holding AB (publ)'s reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Mar 2025 | 48.12k | 0.01% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
